Early ART to Limit Infection and Establishment of Reservoir

NCT02859558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

NETWORK

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]